With only 10 patients all from one location hoping the analysis only takes a couple months. You'd think FDA would also want to see this data before making any decision on AA. Patients being later stage and all on the 75mg dose, it'll be interesting how it compares to 201 results, would be great to see some more patients added to the 3 responders by the 12 months mark but I guess we'll see.
Ann: Alterity Completes Last Patient Visit in Open-Label Trial, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.4M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 1.0¢ | $45.25K | 4.114M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 11296464 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 7952306 | 5 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |